Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemo-Radiotherapy in Extremity Soft Tissue Sarcoma
NCT02812654Phase 2Unknown
- Sponsor
- A.C.Camargo Cancer Center
- Start
- Mar 2015
- Primary completion
- Dec 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, ifosfamide in soft tissue sarcoma (STS), sponsored by A.C.Camargo Cancer Center. Status: unknown.
02
Drugs
doxorubicinifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02812654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812654.